Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015, Article ID 519032, 11 pages
http://dx.doi.org/10.1155/2015/519032
Review Article

Critical Appraisal of International Guidelines for the Management of Diabetic Neuropathy: Is There Global Agreement in the Internet Era?

Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

Received 24 December 2014; Revised 2 March 2015; Accepted 18 March 2015

Academic Editor: Janaka Karalliedde

Copyright © 2015 Mingfang Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Nathan, J. B. Buse, M. B. Davidson et al., “Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: Update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the study of diabetes,” Diabetes Care, vol. 31, no. 1, pp. 173–175, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. J. M. Boulton, R. A. Malik, J. C. Arezzo, and J. M. Sosenko, “Diabetic somatic neuropathies,” Diabetes Care, vol. 27, no. 6, pp. 1458–1486, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Bril, J. England, G. M. Franklin et al., “Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation,” Neurology, vol. 76, no. 20, pp. 1758–1765, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A.-H. Wang, Z.-R. Xu, and L.-N. Ji, “Clinical characteristics and medical costs of diabetics with amputation at central urban hospitals in China,” National Medical Journal of China, vol. 92, no. 4, pp. 224–227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Bril, “Treatments for diabetic neuropathy,” Journal of the Peripheral Nervous System, vol. 17, supplement 2, pp. 22–27, 2012. View at Google Scholar
  6. S. H. Woolf, R. Grol, A. Hutchinson, M. Eccles, and J. Grimshaw, “Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines,” The British Medical Journal, vol. 318, no. 7182, pp. 527–530, 1999. View at Google Scholar
  7. A. L. Francke, M. C. Smit, A. J. E. de Veer, and P. Mistiaen, “Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review,” BMC Medical Informatics and Decision Making, vol. 8, article 38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Thomson, H. McElroy, and M. Sudlow, “Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment,” British Medical Journal, vol. 316, no. 7130, pp. 509–513, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Yan, J. Min, and B. Zhou, “Diagnosis of pheochromocytoma: a clinical practice guideline appraisal using AGREE II instrument,” Journal of Evaluation in Clinical Practice, vol. 19, no. 4, pp. 626–632, 2013. View at Publisher · View at Google Scholar
  10. M. D. Cabana, C. S. Rand, N. R. Powe et al., “Why don't physicians follow clinical practice guidelines? A framework for improvement,” Journal of the American Medical Association, vol. 282, no. 15, pp. 1458–1465, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. A. J. M. Boulton, A. I. Vinik, J. C. Arezzo et al., “Diabetic neuropathies: a statement by the American Diabetes Association,” Diabetes Care, vol. 28, no. 4, pp. 956–962, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Ziegler, “Current concepts in the management of diabetic polyneuropathy,” Current Diabetes Reviews, vol. 7, no. 3, pp. 208–220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Peltier, S. A. Goutman, and B. C. Callaghan, “Painful diabetic neuropathy,” British Medical Journal, vol. 348, Article ID g1799, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. AGREE Collaboration, “Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project,” Quality & Safety in Health Care, vol. 12, pp. 18–23, 2003. View at Google Scholar
  15. Y. Handelsman, J. I. Mechanick, L. Blonde et al., “American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan,” Endocrine Practice, vol. 17, supplement 2, pp. 1–53, 2011. View at Google Scholar · View at Scopus
  16. Scottish Intercollegiate Guidelines Network (SIGN), Management of Diabetes: A National Clinical Guideline, SIGN Publication no. 116, 2010.
  17. National Collaborating Centre for Chronic Conditions, Type 2 Diabetes: National Clinical Guideline for Management in Primary and Secondary Care, update, Royal College of Physicians, London, UK, 2008-2009.
  18. Guidance on the Management of Type 2 Diabetes, 2011, New Zealand Guidelines Group, Wellington, New Zealand, 2011, http://www.nzgg.org.nz/.
  19. International Diabetes Federation, Global Guideline for Type 2 Diabetes. Clinical Guidelines Task Force of IDF, 2012, http://www.idf.org/.
  20. S. Tesfaye, L. Vileikyte, G. Rayman et al., “Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 7, pp. 629–638, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. National Institute for Health and Care Excellence, “Neuropathic pain—pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist settings,” NICE Clinical Guideline 173, 2013. View at Google Scholar
  22. American Diabetes Association, “Standards of Medical Care in Diabetes—2014,” Diabetes Care, vol. 37, Supplement 1, pp. S14–S80, 2013. View at Publisher · View at Google Scholar
  23. N. Attal, G. Cruccu, R. Baron et al., “EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision,” European Journal of Neurology, vol. 17, no. 9, pp. 1113–1123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Hartemann, N. Attal, D. Bouhassira et al., “Painful diabetic neuropathy: diagnosis and management,” Diabetes and Metabolism, vol. 37, no. 5, pp. 377–388, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. UMHS Management of Type 2 Diabetes Mellitus, 2014.
  26. A. M. Tonkin and L. Chen, “Effects of combination lipid therapy in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial,” Circulation, vol. 122, no. 8, pp. 850–852, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. T. D. Wiggin, K. A. Sullivan, R. Pop-Busui, A. Amato, A. A. F. Sima, and E. L. Feldman, “Elevated triglycerides correlate with progression of diabetic neuropathy,” Diabetes, vol. 58, no. 7, pp. 1634–1640, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. H. Diaz, “Validity of the agency for healthcare research and quality clinical practice guidelines: how quickly do guidelines become outdated?” Survey of Anesthesiology, vol. 46, no. 3, pp. 175–176, 2002. View at Publisher · View at Google Scholar
  29. G. Guyatt, E. A. Akl, J. Hirsh et al., “The vexing problem of guidelines and conflict of interest: a potential solution,” Annals of Internal Medicine, vol. 152, no. 11, pp. 738–741, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Raskin, P. D. Donofrio, N. R. Rosenthal et al., “Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects,” Neurology, vol. 63, no. 5, pp. 865–873, 2004. View at Google Scholar